184 related articles for article (PubMed ID: 18036594)
1. Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.
Künzli BM; Nuhn P; Enjyoji K; Banz Y; Smith RN; Csizmadia E; Schuppan D; Berberat PO; Friess H; Robson SC
Gastroenterology; 2008 Jan; 134(1):292-305. PubMed ID: 18036594
[TBL] [Abstract][Full Text] [Related]
2. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease.
Künzli BM; Berberat PO; Giese T; Csizmadia E; Kaczmarek E; Baker C; Halaceli I; Büchler MW; Friess H; Robson SC
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G223-30. PubMed ID: 16920697
[TBL] [Abstract][Full Text] [Related]
4. Deletion of cd39/entpd1 results in hepatic insulin resistance.
Enjyoji K; Kotani K; Thukral C; Blumel B; Sun X; Wu Y; Imai M; Friedman D; Csizmadia E; Bleibel W; Kahn BB; Robson SC
Diabetes; 2008 Sep; 57(9):2311-20. PubMed ID: 18567823
[TBL] [Abstract][Full Text] [Related]
5. Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39/ENTPD1 null mice.
Sun X; Han L; Seth P; Bian S; Li L; Csizmadia E; Junger WG; Schmelzle M; Usheva A; Tapper EB; Baffy G; Sukhatme VP; Wu Y; Robson SC
Hepatology; 2013 Jan; 57(1):205-16. PubMed ID: 22859060
[TBL] [Abstract][Full Text] [Related]
6. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice.
Jackson SW; Hoshi T; Wu Y; Sun X; Enjyoji K; Cszimadia E; Sundberg C; Robson SC
Am J Pathol; 2007 Oct; 171(4):1395-404. PubMed ID: 17823293
[TBL] [Abstract][Full Text] [Related]
7. Extracellular generation of adenosine by the ectonucleotidases CD39 and CD73 promotes dermal fibrosis.
Fernández P; Perez-Aso M; Smith G; Wilder T; Trzaska S; Chiriboga L; Franks A; Robson SC; Cronstein BN; Chan ESL
Am J Pathol; 2013 Dec; 183(6):1740-1746. PubMed ID: 24266925
[TBL] [Abstract][Full Text] [Related]
8. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
9. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
11. Mononuclear-cell-derived microparticles attenuate endothelial inflammation by transfer of miR-142-3p in a CD39 dependent manner.
Kuhn S; Splith K; Ballschuh C; Feldbrügge L; Krenzien F; Atanasov G; Benzing C; Hau HM; Engelmann C; Berg T; Schulte Am Esch J; Pratschke J; Robson SC; Schmelzle M
Purinergic Signal; 2018 Dec; 14(4):423-432. PubMed ID: 30244433
[TBL] [Abstract][Full Text] [Related]
12. CD39 overexpression does not attenuate renal fibrosis in the unilateral ureteric obstructive model of chronic kidney disease.
Roberts V; Lu B; Chia J; Cowan PJ; Dwyer KM
Purinergic Signal; 2016 Dec; 12(4):653-660. PubMed ID: 27565966
[TBL] [Abstract][Full Text] [Related]
13. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
14. Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice.
Sun X; Cárdenas A; Wu Y; Enjyoji K; Robson SC
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G306-11. PubMed ID: 19520738
[TBL] [Abstract][Full Text] [Related]
15. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury.
Köhler D; Eckle T; Faigle M; Grenz A; Mittelbronn M; Laucher S; Hart ML; Robson SC; Müller CE; Eltzschig HK
Circulation; 2007 Oct; 116(16):1784-94. PubMed ID: 17909107
[TBL] [Abstract][Full Text] [Related]
16. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.
Sun X; Wu Y; Gao W; Enjyoji K; Csizmadia E; Müller CE; Murakami T; Robson SC
Gastroenterology; 2010 Sep; 139(3):1030-40. PubMed ID: 20546740
[TBL] [Abstract][Full Text] [Related]
17. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease.
Friedman DJ; Künzli BM; A-Rahim YI; Sevigny J; Berberat PO; Enjyoji K; Csizmadia E; Friess H; Robson SC
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16788-93. PubMed ID: 19805374
[TBL] [Abstract][Full Text] [Related]
18. Attenuated allergic airway inflammation in Cd39 null mice.
Idzko M; K Ayata C; Müller T; Dürk T; Grimm M; Baudiß K; Vieira RP; Cicko S; Boehlke C; Zech A; Sorichter S; Pelletier J; Sévigny J; Robson SC
Allergy; 2013 Apr; 68(4):472-80. PubMed ID: 23452076
[TBL] [Abstract][Full Text] [Related]
19. Variable impact of CD39 in experimental murine colitis.
Künzli BM; Berberat PO; Dwyer K; Deaglio S; Csizmadia E; Cowan P; d'Apice A; Moore G; Enjyoji K; Friess H; Robson SC
Dig Dis Sci; 2011 May; 56(5):1393-403. PubMed ID: 20936356
[TBL] [Abstract][Full Text] [Related]
20. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
